Results 301 to 308 of about 158,775 (308)

Biomarker enrichment strategies: matching trial design to biomarker credentials

Nature Reviews Clinical Oncology, 2013
Boris Freidlin
exaly  

Properties of adaptive, cluster-randomised controlled trials with few clusters: a simulation study

Simulated data files for: Properties of adaptive, cluster-randomised controlled trials with few clusters: a simulation study Data item list: adaptprob.RDS - simulated data from adaptive design trial nonadapt.RDS - simulated data for non-adaptive trial sensseedXXX.RDS - simulated data for adaptive trial with varying seeds for sensitivity analysis ...
openaire   +1 more source

Molecular cancer prevention: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2015
Kenneth Y Tsai, Powel H Brown, Eva Szabo
exaly  

A randomized trial of normothermic preservation in liver transplantation

Nature, 2018
David Nasralla, Hynek Mergental, Virginia Chiocchia   +2 more
exaly  

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Nature Medicine, 2019
Hugo Horlings, Koen Van de Vijver, Iris Nederlof   +2 more
exaly  

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Nature Medicine, 2018
Andrew N J Tutt, Holly Tovey, Maggie Chon U Cheang   +2 more
exaly  

Research Explained: Cluster randomised controlled trial: shade for Australian adolescents

BMJ, 2009
openaire   +1 more source

Physician characteristics associated with clinical trial enrollment

Ca-A Cancer Journal for Clinicians, 2011
exaly